Abstract
A pilot study on 10 consecutive patients with newly diagnosed glaucoma and a randomised double-blind study on 18 patients with glaucoma were carried out to investigate the effect of pindolol, a beta-adrenergic blocking agent, on the intraocular pressure (IOP) in patients with glaucoma. The studies showed that pindolol may reduce the IOP and that no significant difference between the effect of timolol 0.5% and of pindolol 0.25% could be demonstrated. The serum concentration of pindolol was measured in 9 of the patients, but none had measurable serum levels.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonomi I., Steindler P. Effect of pindolol on intraocular pressure. Br J Ophthalmol. 1975 Jun;59(6):301–303. doi: 10.1136/bjo.59.6.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Degen P. H., Riess W. Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography. J Chromatogr. 1976 Jun 9;121(1):72–75. doi: 10.1016/s0021-9673(00)82299-2. [DOI] [PubMed] [Google Scholar]
- Rowley S., Staunton J. E., Tosch A., Stewart-Jones J. H., Edgar D. F., Turner P. A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects. Br J Ophthalmol. 1981 Aug;65(8):536–538. doi: 10.1136/bjo.65.8.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith S. E., Smith S. A., Reynolds F., Whitmarsh V. B. Ocular and cardiovascular effects of local and systemic pindolol. Br J Ophthalmol. 1979 Jan;63(1):63–66. doi: 10.1136/bjo.63.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tyas C., Stewart-Jones J. H., Edgar D. F., Turner P. The effect of 0.25% and 0.5% pindolol in intraocular pressure in normal human volunteers. Curr Med Res Opin. 1981;7(8):550–552. doi: 10.1185/03007998109112372. [DOI] [PubMed] [Google Scholar]
- Vale J., Gibbs A. C., Phillips C. I. Topical propranolol and ocular tension in the human. Br J Ophthalmol. 1972 Oct;56(10):770–775. doi: 10.1136/bjo.56.10.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vale J., Phillips C. I. Practolol (Eraldin) eye drops as an ocular hypotensive agent. Br J Ophthalmol. 1973 Mar;57(3):210–214. doi: 10.1136/bjo.57.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wettrell K., Pandolfi M. Effect of topical atenolol on intraocular pressure. Br J Ophthalmol. 1977 May;61(5):334–338. doi: 10.1136/bjo.61.5.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zimmerman T. J., Boger W. P., 3rd The beta-adrenergic blocking agents and the treatment of glaucoma. Surv Ophthalmol. 1979 May-Jun;23(6):347–362. doi: 10.1016/0039-6257(79)90228-5. [DOI] [PubMed] [Google Scholar]
- Zimmerman T. J., Kaufman H. E. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol. 1977 Apr;95(4):601–604. doi: 10.1001/archopht.1977.04450040067008. [DOI] [PubMed] [Google Scholar]